Phenytoin toxicity: Difference between revisions
No edit summary |
|||
| Line 48: | Line 48: | ||
*Cannot base on phenytoin level (erratic absorption after PO overdose) | *Cannot base on phenytoin level (erratic absorption after PO overdose) | ||
**Consider discharge if pt has only mild symptoms and serial phenytoin levels decline | **Consider discharge if pt has only mild symptoms and serial phenytoin levels decline | ||
==See Also== | |||
*[[Phenytoin]] | |||
==References== | ==References== | ||
[[Category:Tox]] | [[Category:Tox]] | ||
Revision as of 01:00, 1 October 2015
Background
- Mortality is extremely rare after intentional overdose if good supportive care is provided
- Rapid IV dosing carries greatest risk (due to propylene glycol constituent of IV form --> myocardia depression & cardiac arrest)
- 90% protein bound; dialysis ineffective
Clinical Features
- CV (only with IV form)
- Bradycardia
- Hypotension
- Vfib
- Asystole
- Neuro
- Nystagmus
- First only with forced lateral gaze; later becomes spontaneous
- May disappear at higher levels
- Ataxia
- Decreased LOC
- Nystagmus
- GI
- Skin
- tissue infiltration (IV) --> "purple glove syndrome"
- edema, pain, ischemia, tissue necrosis, compartment syndrome
- Anticonvulsant hypersensitivity syndrome
Differential Diagnosis
Diagnosis
- Phenytoin level
- Provides a rough guide only; neither sensitive nor specific
- Level >10: usually no symptoms
- Level 10-20: Occasional mild nystagmus
- Level 20-30: Nystagmus
- Level 30-40: Ataxia, slurred speech, N/V
- Level 40-50: Lethargy, confusion
- Level >50: Coma, seizure (rare)
Treatment
- Detoxification
- Bradyarrhythmias
- Atropine, pacing
- Hypotension
Disposition
- Cannot base on phenytoin level (erratic absorption after PO overdose)
- Consider discharge if pt has only mild symptoms and serial phenytoin levels decline
